Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
algorithm
andexanet
anticoagulant, complications of
anticoagulant, discontinuation
anticoagulant, reversal of
anticoagulant, treatment
apixaban
cerebrospinal fluid
ciraparantag
coagulopathy
complications
controversies in neurology
cost
cost effectiveness
coumarin
dabigatran
efficacy
emergencies, neurologic
facial nerve palsy
factor Xa inhibitor
fresh frozen plasma
heart valve, prosthetic
hemostatic therapy
idarucizumab
INR values
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, volume
mortality
non-vitamin K antagonist oral anticoagulants
practice guidelines
prothrombin complex concentrate
review article
safety
treatment of neurologic disorder
vitamin K
Showing articles 400 to 450 of 3394 << Previous Next >>

Carotid Stenosis Role of Plaque Morphology in Recurrent Stroke Risk
Stroke 48:e197-e199, Silverman, S. & Sundararajan, S., 2017

Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017

Clinicopathologic Conference, Probable Acute Leptospirosis
NEJM 377:268-278, Case 22-2017, 2017

Intravenous Immune Globulin: Adverse Effects
UptoDate June, Perez, E.E. & Silvergleid, A.J., 2017

Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017

Migraine
NEJM 377:553-561, Charles, A., 2017

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
NEJM 377:431-441, Pollack, C.V.,et al, 2017

Association Between Cirrhosis and Stroke in a Nationally Representative Cohort
JAMA Neurol 74:927-932, Parikh, N.S.,et al, 2017

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Court
JAMA Neurol 74:933-940,901, Jennings, D.,et al, 2017

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Recrudescence of Deficits After Stroke
JAMA Neurol 74:1048-1055, Topcuoglu, M.A.,et al, 2017

Cerebral Venous Sinus Thrombosis in Homocystinuria: Dietary Intervention in Conjunction with Anticoagulation
Sage Open Med Case Reports 5:1-4, Yap, S.,et al, 2017

Guillain-Barre Syndrome following tuberculosis: A rare association
J Neurosci Rural Pract 8:296-299, Lakhotia, A.N.,et al, 2017

Lymphocytic Choriomeningitis Virus (LCMV) Infection
www.Medscape.com Sept, McDonald, P.J.,et al, 2017

Posterior Ischemic Optic Neuropathy
UptoDate Aug, Tamhankar, M. & Volpe, N., 2017

Viral Hepatitis and Parkinson Disease
Neurol 88:1630-1633, Pakpoor, J.,et al, 2017

Feasibility and Diagnostic Value of Cardiovascular Magnetic Resonance Imaging after Acute Ischemic Stroke of Undetermined Origin
Stroke 48:1241-1247, Haeusler, K.G.,et al, 2017

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
NEJM 376:1627-1636, Calkins, H.,et al, 2017

Migraine and Risk of Perioperative Ischemic Stroke and Hospital Readmission: Hospital Based Registry Study
BMJ 356:e6635, Timm. F.P.,et al, 2017

Sudden-Onset Pulsatile Headache in a Previously Healthy Young Man
Neurol 88:e26-e29, Qin, C.,et al, 2017

Disparities and Guideline Adherence in Drugs of Abuse Screening in Intracerebral Hemorrhage
Neurol 88:252-258, Tomoehlen, L.M.,et al, 2017

Association of Antithrombotic Drug Use with Subdural Hematoma Risk
JAMA 317:836-846, Gaist, D.,et al, 2017

Investigations in GABA? Receptor Antibody-Associated Encephalitis
Neurol 88:1012-1020,1010, Spatola, M.,et al, 2017

Clinicopathologic Conference Cryptococcal Meningitis in a Patient with Chronic HIV Infection
NEJM 376:1065-1071, Case 8-2017, 2017

Management of Sciatica
NEJM 376:1175-1177, Ramaswami, Ramya, 2017

Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017

Neurological Autoantibody Prevalence in Epilepsy on Unknown Etiology
JAMA Neurol 74:397-402,384, Dubey, D.,et al, 2017

Cervical Artery Dissection in Patients = 60
Neurol 88:1313-1320, Traenka, C.,et al, 2017

Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia
Stroke 48:1139-1146, Pase, M.P.,et al, 2017

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis
JAMA Neurol 74:60-66, Robeson, K.R.,et al, 2017

Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barre Syndrome
JAMA Neurol 74:26-33, Stevens, O.,et al, 2017

Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017

Cardiac Magnetic Resonance Imaging: A New Tool to Identify Cardioaortic Sources in Ischaemic Stroke
JNNP 88:31-37, Yaghi, S.,et al, 2017

Carotid Artery Web and Ischemic Stroke
Neurol 88:65-69, Coutinho, J.M.,et al, 2017

Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke
Stroke 48:501-506, Caso, V.,et al, 2017

Stroke as the Initial Manifestation of Atrial Fibrillation
Stroke 48:490-492, Lubitz, S.A.,et al, 2017

D-Dimer as a Predictor of Early Neurologic Deterioration in Cryptogenic Stroke with Active Cancer
Eur J Neurol 24:205-211, Nam, K.-W.,et al, 2017

Stroke
Lancet 389:641-654, Hankey, G.J., 2017

Non-Specific Low Back Pain
Lancet 389:736-747, Maher, C.,et al, 2017

Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator
NEJM 376:755-764, Russo, R.J.,et al, 2017

Simultaneous Multiple Intracerebral Hemorrhages (SMICH)
Stroke 48: 581-586, Wu, T.Y.,et al, 2017

Risk of Pulmonary Embolism After Cerebral Venous Thrombosis
Stroke 48:563-567, Liberman, A.L.,et al, 2017

Subarachnoid Hemorrhage
Medscape Aug, Becske, T. & Lutsep, H.L., 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Chikungunya Virus-Associated Encephalitis
Neurol 86:94-102, Gerardin, P.,et al, 2016

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Retinal Artery Occlusion and the Risk of Stroke Development
Stroke 47:376-382, Hyungtaek, T.,et al, 2016

Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016



Showing articles 400 to 450 of 3394 << Previous Next >>